![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
RA Houghtling, MI Davila-Garcia and KJ Kellar
Department of Pharmacology, Georgetown University School of Medicine, Washington, D. C. 20007, USA.
Epibatidine is an alkaloid that was first isolated from the skin of the Ecuadoran frog Epipedobates tricolor by Daly et al. [J. Am. Chem. Soc. 102:803-836 (1980)] and was found to have very high affinity for neuronal nicotinic receptors, where it acts as a potent agonist. Here we have measured and characterized the binding of (+/-)(- )[3H]epibatidine to nicotinic receptors in rat brain. In rat forebrain homogenates, (+/-)(-)[3H]epibatidine binds to two sites, with apparent affinities of 15 pM and 360 pM. Both of these binding sites have pharmacological profiles consistent with neuronal nicotinic receptors and a similar brain regional distribution. (+/-)(-)[3H]Epibatidine also binds to sites in rat adrenal gland, suggesting that it can label a subtype of nicotinic receptor found in peripheral ganglia as well as the subtype that predominates in brain. In human cerebral cortex as well, (+/-)(-)[3H]epibatidine binds two sites, one of which appears to have an affinity of < 1 pM. We conclude that (+/-)(-)[3H]epibatidine should be a very useful new tool for characterizing the properties and regulation of neuronal nicotinic receptors, including those not easily measurable with other radioligands.
This article has been cited by other articles:
|
|
 |
|
  C. Gotti, M. Moretti, N. M. Meinerz, F. Clementi, A. Gaimarri, A. C. Collins, and M. J. Marks Partial Deletion of the Nicotinic Cholinergic Receptor {alpha}4 or {beta}2 Subunit Genes Changes the Acetylcholine Sensitivity of Receptor-Mediated 86Rb+ Efflux in Cortex and Thalamus and Alters Relative Expression of {alpha}4 and {beta}2 Subunits Mol. Pharmacol., June 1, 2008; 73(6): 1796 - 1807. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C. Drisdel, D. Sharp, T. Henderson, T. G. Hales, and W. N. Green High Affinity Binding of Epibatidine to Serotonin Type 3 Receptors J. Biol. Chem., April 11, 2008; 283(15): 9659 - 9665. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Marks, P. Whiteaker, and A. C. Collins Deletion of the {alpha}7, beta2, or beta4 Nicotinic Receptor Subunit Genes Identifies Highly Expressed Subtypes with Relatively Low Affinity for [3H]Epibatidine Mol. Pharmacol., September 1, 2006; 70(3): 947 - 959. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Person, K. L. Bills, H. Liu, S. K. Botting, J. Lindstrom, and G. B. Wells Extracellular Domain Nicotinic Acetylcholine Receptors Formed by {alpha}4 and {beta}2 Subunits J. Biol. Chem., December 2, 2005; 280(48): 39990 - 40002. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Turner and K. J. Kellar Nicotinic Cholinergic Receptors in the Rat Cerebellum: Multiple Heteromeric Subtypes J. Neurosci., October 5, 2005; 25(40): 9258 - 9265. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-H. Peng, J. D. Fryer, R. S. Hurst, K. M. Schroeder, A. A. George, S. Morrissy, V. E. Groppi, S. S. Leonard, and R. J. Lukas High-Affinity Epibatidine Binding of Functional, Human {alpha}7-Nicotinic Acetylcholine Receptors Stably and Heterologously Expressed de Novo in Human SH-EP1 Cells J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 24 - 35. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Parker, Y. Fu, K. McAllen, J. Luo, J. M. McIntosh, J. M. Lindstrom, and B. M. Sharp Up-Regulation of Brain Nicotinic Acetylcholine Receptors in the Rat during Long-Term Self-Administration of Nicotine: Disproportionate Increase of the {alpha}6 Subunit Mol. Pharmacol., March 1, 2004; 65(3): 611 - 622. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Eaton, J.-H. Peng, K. M. Schroeder, A. A. George, J. D. Fryer, C. Krishnan, L. Buhlman, Y.-P. Kuo, O. Steinlein, and R. J. Lukas Characterization of Human {alpha}4{beta}2-Nicotinic Acetylcholine Receptors Stably and Heterologously Expressed in Native Nicotinic Receptor-Null SH-EP1 Human Epithelial Cells Mol. Pharmacol., December 1, 2003; 64(6): 1283 - 1294. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. W. Fitch, Y. Xiao, K. J. Kellar, and J. W. Daly Membrane potential fluorescence: A rapid and highly sensitive assay for nicotinic receptor channel function PNAS, April 15, 2003; 100(8): 4909 - 4914. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Plenge, E. T. Mellerup, and G. Wortwein Characterization of Epibatidine Binding to Medial Habenula: Potential Role in Analgesia J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 759 - 765. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Whiteaker, C. G. Peterson, W. Xu, J. M. McIntosh, R. Paylor, A. L. Beaudet, A. C. Collins, and M. J. Marks Involvement of the alpha 3 Subunit in Central Nicotinic Binding Populations J. Neurosci., April 1, 2002; 22(7): 2522 - 2529. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Kulak, J. M. McIntosh, and M. Quik Loss of Nicotinic Receptors in Monkey Striatum after 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Treatment Is Due to a Decline in alpha -Conotoxin MII Sites Mol. Pharmacol., January 1, 2002; 61(1): 230 - 238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Xiao, R. D. Smith, F. S. Caruso, and K. J. Kellar Blockade of Rat alpha 3beta 4 Nicotinic Receptor Function by Methadone, Its Metabolites, and Structural Analogs J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 366 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Hilmas, E. F. R. Pereira, M. Alkondon, A. Rassoulpour, R. Schwarcz, and E. X. Albuquerque The Brain Metabolite Kynurenic Acid Inhibits {alpha}7 Nicotinic Receptor Activity and Increases Non-{alpha}7 Nicotinic Receptor Expression: Physiopathological Implications J. Neurosci., October 1, 2001; 21(19): 7463 - 7473. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Meyer, Y. Xiao, and K. J. Kellar Agonist Regulation of Rat alpha 3beta 4 Nicotinic Acetylcholine Receptors Stably Expressed in Human Embryonic Kidney 293 Cells Mol. Pharmacol., September 1, 2001; 60(3): 568 - 576. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. P. Dwoskin and P. A. Crooks Competitive Neuronal Nicotinic Receptor Antagonists: A New Direction for Drug Discovery J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 395 - 402. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Buisson and D. Bertrand Chronic Exposure to Nicotine Upregulates the Human {alpha}4{beta}2 Nicotinic Acetylcholine Receptor Function J. Neurosci., March 15, 2001; 21(6): 1819 - 1829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Zheng, K. Olivier, Y. K. Won, and C. N. Pope Comparative Cholinergic Neurotoxicity of Oral Chlorpyrifos Exposures in Preweanling and Adult Rats Toxicol. Sci., May 1, 2000; 55(1): 124 - 132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Mukhin, D. Gündisch, A. G. Horti, A. O. Koren, G. Tamagnan, A. S. Kimes, J. Chambers, D. B. Vaupel, S. L. King, M. R. Picciotto, et al. 5-Iodo-A-85380, an alpha 4beta 2 Subtype-Selective Ligand for Nicotinic Acetylcholine Receptors Mol. Pharmacol., March 1, 2000; 57(3): 642 - 649. [Abstract] [Full Text]
|
|
|
|
|
|
D. C. Perry, M. I. Dávila-García, C. A. Stockmeier, and K. J. Kellar Increased Nicotinic Receptors in Brains from Smokers: Membrane Binding and Autoradiography Studies J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1545 - 1552. [Abstract] [Full Text]
|
|
|
|
|
|
M. J. Marks, P. Whiteaker, J. Calcaterra, J. A. Stitzel, A. E. Bullock, S. R. Grady, M. R. Picciotto, J.-P. Changeux, and A. C. Collins Two Pharmacologically Distinct Components of Nicotinic Receptor-Mediated Rubidium Efflux in Mouse Brain Require the beta 2 Subunit J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 1090 - 1103. [Abstract] [Full Text]
|
|
|
|
|
|
R. D. Mellon and B. M. Bayer The Effects of Morphine, Nicotine and Epibatidine on Lymphocyte Activity and Hypothalamic-Pituitary-Adrenal Axis Responses J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 635 - 642. [Abstract] [Full Text]
|
|
|
|
|
|
J. Cuevas and D. K. Berg Mammalian Nicotinic Receptors with alpha 7 Subunits That Slowly Desensitize and Rapidly Recover from alpha -Bungarotoxin Blockade J. Neurosci., December 15, 1998; 18(24): 10335 - 10344. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Parker, A. Beck, and C. W. Luetje Neuronal Nicotinic Receptor beta 2 and beta 4 Subunits Confer Large Differences in Agonist Binding Affinity Mol. Pharmacol., December 1, 1998; 54(6): 1132 - 1139. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Xiao, E. L. Meyer, J. M. Thompson, A. Surin, J. Wroblewski, and K. J. Kellar Rat alpha 3/beta 4 Subtype of Neuronal Nicotinic Acetylcholine Receptor Stably Expressed in a Transfected Cell Line: Pharmacology of Ligand Binding and Function Mol. Pharmacol., August 1, 1998; 54(2): 322 - 333. [Abstract] [Full Text]
|
|
|
|
|
|
P. Whiteaker, C. G. V. Sharples, and S. Wonnacott Agonist-Induced Up-Regulation of alpha 4beta 2 Nicotinic Acetylcholine Receptors in M10 Cells: Pharmacological and Spatial Definition Mol. Pharmacol., May 1, 1998; 53(5): 950 - 962. [Abstract] [Full Text]
|
|
|
|
|
|
M. J. Marks, K. W. Smith, and A. C. Collins Differential Agonist Inhibition Identifies Multiple Epibatidine Binding Sites in Mouse Brain J. Pharmacol. Exp. Ther., April 1, 1998; 285(1): 377 - 386. [Abstract] [Full Text]
|
|
|
|
|
|
W. G. Conroy and D. K. Berg Nicotinic Receptor Subtypes in the Developing Chick Brain: Appearance of a Species Containing the alpha 4, beta 2, and alpha 5 Gene Products Mol. Pharmacol., March 1, 1998; 53(3): 392 - 401. [Abstract] [Full Text]
|
|
|
|
|
|
M. I. Dávila-García, J. L. Musachio, D. C. Perry, Y. Xiao, A. Horti, E. D. London, R. F. Dannals, and K. J. Kellar [125I]IPH, an Epibatidine Analog, Binds with High Affinity to Neuronal Nicotinic Cholinergic Receptors J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 445 - 451. [Abstract] [Full Text]
|
|
|
|
|
|
A. I. Sacaan, R. T. Reid, E. M. Santori, P. Adams, L. D. Correa, L. S. Mahaffy, L. Bleicher, N. D. P. Cosford, K. A. Stauderman, I. A. McDonald, et al. Pharmacological Characterization of SIB-1765F: A Novel Cholinergic Ion Channel Agonist J. Pharmacol. Exp. Ther., January 1, 1997; 280(1): 373 - 383. [Abstract] [Full Text]
|
|
|
|
|
|
C. M. Flores, R. M. DeCamp, S. Kilo, S. W. Rogers, and K. M. Hargreaves Neuronal Nicotinic Receptor Expression in Sensory Neurons of the Rat Trigeminal Ganglion: Demonstration of alpha 3beta 4, a Novel Subtype in the Mammalian Nervous System J. Neurosci., December 15, 1996; 16(24): 7892 - 7901. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. M. Khan, K. L. Youngblood, M. P. Printz, T. L. Yaksh, and P. Taylor Spinal Nicotinic Receptor Expression in Spontaneously Hypertensive Rats Hypertension, December 1, 1996; 28(6): 1093 - 1099. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
